BJ
CLVS

BlackRock Japan’s Clovis Oncology, Inc. CLVS Stock Holding History

BlackRock Japan’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$10K Buy
236
+24
+11% +$845 ﹤0.01% 1225
2016
Q3 		$8K Buy
+212
New +$4.55K ﹤0.01% 1228
2016
Q2 		– Sell
-547
Closed -$11K – 1512
2016
Q1 		$11K Hold
547
– – ﹤0.01% 1281
2015
Q4 		$19K Buy
547
+204
+59% +$13.2K ﹤0.01% 1171
2015
Q3 		$32K Buy
343
+33
+11% +$2.86K ﹤0.01% 1043
2015
Q2 		$27K Buy
310
+149
+93% +$12.8K ﹤0.01% 1154
2015
Q1 		$12K Buy
+161
New +$11.4K ﹤0.01% 1228
2014
Q2 		– Sell
-413
Closed -$29K – 1429
2014
Q1 		$29K Buy
+413
New +$30.3K ﹤0.01% 1235

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return